Jump to content

Search the Community

Showing results for tags 'emapunil'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Research - Actively Recruiting
    • Research Advertisements
  • Main Forums
    • PREPARATION FOR LIVESTREAMS
    • MAIN AND GENERAL FORUM
    • Introductions
    • Symptoms: Descriptions, Discussion, Debate
    • Medications & Other Treatments
  • Active and Future Research
    • Research Articles, Publications and Studies
  • Community Area
    • Community Open Space
    • Forum Information, Questions and Suggestions

Categories

There are no results to display.

There are no results to display.

Product Groups

There are no results to display.


Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


AIM


MSN


Website URL


ICQ


Yahoo


Jabber


Skype


Location


Interests


Administration Role

Found 1 result

  1. File Name: Translocator Protein (18 kD) as Target for anxiolytics without benzodiazepine-like side effects File Submitter: StateOfRegret File Submitted: 10 Mar 2014 File Category: Publications A study on Emapunil, novel anxiolytic. Abstract: Most antianxiety drugs (anxiolytics) work by modulating neurotransmitters in the brain. Benzodiazepines are fast and effective anxiolytic drugs; however, their long-term use is limited by the development of tolerance and withdrawal symptoms. Ligands of the translocator protein [18 kilodaltons (kD)] may promote the synthesis of endogenous neurosteroids, which also exert anxiolytic effects in animal models. Here, we found that the translocator protein (18 kD) ligand XBD173 enhanced gamma-aminobutyric acid-mediated neurotransmission and counteracted induced panic attacks in rodents in the absence of sedation and tolerance development. XBD173 also exerted antipanic activity in humans and, in contrast to benzodiazepines, did not cause sedation or withdrawal symptoms. Thus, translocator protein (18 kD) ligands are promising candidates for fast-acting anxiolytic drugs with less severe side effects than benzodiazepines. Click here to download this file
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.